Home LiteratureArticle Details
PMID: 12075714 Published · ppublish English Case Reports Journal Article

Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection.

Journal of the Medical Association of Thailand = Chotmaihet thangphaet ·Vol. 85 ·No. 1 ·2002-01-00 ·Pages 131-4

Kengsakul K, Sathirapongsasuti K, Punyagupta S

Abstract

A 53 year old physically healthy man, unaware of any immunocompromised condition developed rapidly fatal myelomeningoencephalitis following a live-attenuated yellow fever vaccination. He was found to have asymptomatic HIV infection with high viral loads and low CD4 counts. This is the first reported case of such an incidence in the world literature. It is strongly suggested that in countries where HIV infection is endemic, an HIV blood test should be performed prior to the yellow fever vaccination and the vaccine should not be given to those immunocompromised persons.

MeSH Terms
Encephalomyelitis/diagnosis,immunology Fatal Outcome HIV Infections/diagnosis,immunology Humans Immunocompromised Host Male Middle Aged Risk Assessment Vaccination/adverse effects Yellow Fever/immunology,prevention & control Yellow Fever Vaccine/administration & dosage,adverse effects
Chemicals
Yellow Fever Vaccine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Kengsakul Kitisak
Department of Medicine, Vichaiyut Hospital, Bangkok, Thailand.
Sathirapongsasuti Kriengkrai
Punyagupta Sompone
Article Info
Journal
Journal of the Medical Association of Thailand = Chotmaihet thangphaet
Abbr.
J Med Assoc Thai
ISSN
0125-2208
Published
2002-01-00
Pages
131-4
Language
English
Region
Thailand
NLM ID
7507216
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com